Cathy Hilliard

Cathy Hilliard is an experienced Oncology Clinical Scientist at Merck, where they lead and support late-stage melanoma trials. Previously, Cathy served as an Associate Principal Scientist at Merck, executing GLP testing in Genetic Toxicology and contributing to regulatory submissions. They have also held roles as a Cytogenetic Analyst at the National University of Ireland, Galway, and as a Research Technician at The Children's Hospital of Philadelphia, working on pivotal studies for the human genome project. Cathy earned their M.S. in Biomedical Chemistry from Jefferson Health and a B.A. in Biology from Kaplan College.